FRUZAQLA (fruquintinib) Dinner Program- March 27

About:
The program will discuss Introducing the First and Only Novel Targeted Therapy Approved in mCRC, Regardless of Mutation Status, in More Than a Decade.

Presented by:
Farshid Dayanni, MD, PhD, Professor of Clinical Medicine
University of California, Irvine

When:
Wednesday, March 27 at 6:30pm

Where:
Fleming’s Prime Steakhouse, 180 El Camino Real Ste. 2 Palo Alto, CA